Back
Gilead Sciences Vs. Vertex Pharmaceuticals Industry Stock Comparison
Buy
63
GILD
Gilead Sciences
Last Price:
94.34
Seasonality Move:
9.71%
Buy
62
VRTX
Vertex Pharmaceuticals
Last Price:
489.96
Seasonality Move:
7.3%
Buy
63
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $97.03. The Score for GILD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $501.72. The Score for VRTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $97.03
The current trend is moderately bullish and GILD is experiencing slight selling pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $501.72
The current trend is moderately bullish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.98 | Buy |
| Relative Strength Index (14 RSI): | 78.92 | Buy |
| Chaikin Money Flow: | -2697841 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (84.98 - 92.3) | Buy |
| Bollinger Bands (100): | (71.86 - 86.6) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.8 | Buy |
| Relative Strength Index (14 RSI): | 59.34 | Buy |
| Chaikin Money Flow: | -1078271 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (465.89 - 494.31) | Buy |
| Bollinger Bands (100): | (466.44 - 491.36) | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.7 | Buy |
| 20-day SMA: | 89.52 | Buy |
| 50-day SMA: | 85.49 | Buy |
| 200-day SMA: | 74.54 | Buy |
| 8-day EMA: | 93.6 | Buy |
| 20-day EMA: | 90.33 | Buy |
| 50-day EMA: | 85.82 | Buy |
| 200-day EMA: | 77.99 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 491.86 | Buy |
| 20-day SMA: | 483.44 | Buy |
| 50-day SMA: | 475.48 | Buy |
| 200-day SMA: | 452.3 | Buy |
| 8-day EMA: | 495.51 | Buy |
| 20-day EMA: | 485.4 | Buy |
| 50-day EMA: | 478.85 | Buy |
| 200-day EMA: | 451.35 | Buy |
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.46 per share, and an increase next year of $3.16 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.57 per share, and an increase next year of $18.26 per share.
Gilead Sciences Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||